SIMPLEX TRADING, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157F953. A total of 4 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$226
-5.0%
11,800
+25.5%
0.00%
Q2 2023$238
-88.6%
9,400
-83.8%
0.00%
-100.0%
Q1 2023$2,096
+703.1%
58,000
+778.8%
0.00%
Q4 2022$261
-100.0%
6,600
-70.4%
0.00%
-100.0%
Q3 2022$1,039,000
+357.7%
22,300
+328.8%
0.00%
Q2 2022$227,000
-55.1%
5,200
-25.7%
0.00%
Q1 2022$506,000
+228.6%
7,000
+268.4%
0.00%
Q4 2021$154,000
-71.1%
1,900
-40.6%
0.00%
Q3 2021$532,000
+0.4%
3,2000.0%0.00%
-100.0%
Q2 2021$530,000
+15.2%
3,200
+9597.0%
0.00%0.0%
Q1 2021$460,000
-14.2%
33
+6.5%
0.00%0.0%
Q4 2020$536,000
+4.1%
31
-16.2%
0.00%0.0%
Q3 2020$515,000
-49.3%
37
-56.5%
0.00%
-50.0%
Q2 2020$1,015,000
+182.7%
85
+136.1%
0.00%
+100.0%
Q1 2020$359,000
-91.6%
36
-90.1%
0.00%
-88.9%
Q4 2019$4,290,000
+148.4%
365
+81.6%
0.01%
+80.0%
Q3 2019$1,727,000
+80.1%
201
+35.8%
0.01%
+66.7%
Q2 2019$959,000
-25.5%
148
-28.2%
0.00%
-25.0%
Q1 2019$1,287,000
+524.8%
206
+288.7%
0.00%
+300.0%
Q4 2018$206,000
-44.3%
53
-18.5%
0.00%0.0%
Q3 2018$370,000
+49.8%
65
+109.7%
0.00%0.0%
Q2 2018$247,000
+1664.3%
31
-55.1%
0.00%0.0%
Q1 2018$14,000
-48.1%
69
+263.2%
0.00%0.0%
Q4 2017$27,000
+17.4%
19
+46.2%
0.00%0.0%
Q3 2017$23,000
+130.0%
13
-75.0%
0.00%
Q2 2017$10,000
-63.0%
52
-32.5%
0.00%
-100.0%
Q1 2017$27,000
-56.5%
77
+18.5%
0.00%
-75.0%
Q4 2016$62,000
+588.9%
65
+51.2%
0.00%
+300.0%
Q3 2016$9,000
-64.0%
43
+126.3%
0.00%
-50.0%
Q2 2016$25,000
-59.7%
19
-89.1%
0.00%
-60.0%
Q1 2016$62,000
+313.3%
174
-10.3%
0.01%
+400.0%
Q4 2015$15,000
-55.9%
194
+158.7%
0.00%
-50.0%
Q3 2015$34,000
+126.7%
75
+50.0%
0.00%
+100.0%
Q2 2015$15,000500.00%
Other shareholders
NEVRO CORP shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 798$5,387,0000.30%
GROUP ONE TRADING, L.P. 3,500$236,0000.00%
SIMPLEX TRADING, LLC 194$15,0000.00%
Citadel Advisors 6,100$412,0000.00%
View complete list of NEVRO CORP shareholders